- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
| Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
|---|---|---|---|---|---|---|
| Trial Vendor Associate Director | Dublin (NOCC) | Ireland | Development | Innovative Medicines | Research & Development | Jan 08, 2025 |
| Trial Vendor Associate Director Community Lead | Dublin (NOCC) | Ireland | Development | Innovative Medicines | Research & Development | Jan 07, 2025 |
| Head of Public Affairs, Ireland | Dublin (Country President Office (CPO)) | Ireland | Corporate Affairs | Innovative Medicines | Communications & Public Affairs | Dec 12, 2024 |
| Associate Director Technology and Scientific Computing | Dublin (NOCC) | Ireland | Development | Innovative Medicines | Data and Digital | Dec 09, 2024 |
| Trial Vendor Senior Manager | Dublin (NOCC) | Ireland | Development | Innovative Medicines | Research & Development | Dec 04, 2024 |
| Associate Director RWE Manager | Dublin (NOCC) | Ireland | Operations | CTS | Market Access | Dec 03, 2024 |
| Associate Director, QC IT Technical Solution Delivery | Ljubljana | Ireland | Operations | CTS | Technology Transformation | Dec 03, 2024 |
| Global Regulatory Publishing Associate | Dublin (NOCC) | Ireland | Development | Innovative Medicines | Research & Development | Dec 03, 2024 |
| Associate Director, CD Diversity, Equity & Inclusion | Dublin (Country President Office (CPO)) | Ireland | Development | Innovative Medicines | Research & Development | Dec 02, 2024 |
| P&O Senior Program and Project Manager | Dublin (Country President Office (CPO)) | Ireland | People & Organization | CTS | Human Resources | Dec 02, 2024 |
| Head of Occupational Health and Safety Governance | Dublin (NOCC) | Ireland | Ethics Risk & Compliance | Corporate | Facilities & Administration | Nov 27, 2024 |
| Snr. Global Program Regulatory Manager | Dublin (NOCC) | Ireland | Development | Innovative Medicines | Research & Development | Nov 27, 2024 |
| Associate Clinical Development Medical Director | Dublin (NOCC) | Ireland | Development | Innovative Medicines | Research & Development | Nov 21, 2024 |
| Associate Director Biostatistics | Dublin (NOCC) | Ireland | Development | Innovative Medicines | Research & Development | Nov 15, 2024 |
| Senior Principal Biostatistician | Dublin (NOCC) | Ireland | Development | Innovative Medicines | Research & Development | Nov 15, 2024 |
| Global Labelling Manager | Dublin (NOCC) | Ireland | Development | Innovative Medicines | Research & Development | Nov 05, 2024 |
| Site HSE Head & Cluster Lead | Dublin (NOCC) | Ireland | Operations | CTS | Facilities & Administration | Nov 01, 2024 |
| CISR Committee Lead | Dublin (NOCC) | Ireland | Development | Innovative Medicines | Research & Development | Oct 14, 2024 |
| Associate Director, Clinical Processes & Solutions | Dublin (NOCC) | Ireland | Development | Innovative Medicines | Research & Development | Oct 14, 2024 |
| Principal Clinical Data Manager | Dublin (NOCC) | Ireland | Development | Innovative Medicines | Research & Development | Sep 26, 2024 |
| Real World Evidence Research Analyst | Dublin (NOCC) | Ireland | Operations | CTS | Market Access | Aug 12, 2024 |
| Senior Medical Information Manager 2 | Dublin (NOCC) | Ireland | Operations | CTS | Research & Development | Apr 23, 2024 |
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى